Trial Profile
Prospective randomized trial concerning three different stimulation methods in IVF/ICSI treatment in poor responders
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 10 Aug 2023
Price :
$35
*
At a glance
- Drugs Corifollitropin alfa (Primary) ; Follitropin beta
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms POOR RESPONDERS
- 10 Aug 2023 Status changed from recruiting to discontinued.
- 21 Aug 2014 New trial record